Global Retinitis Pigmentosa (Retinitis) Market Research Report 2023

Request Sample Report

Pre-Order Enquiry

Request Discount(%)

1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Retinitis Pigmentosa (Retinitis) Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
        1.2.2 General Treatment
        1.2.3 Traditional Chinese Medicine
        1.2.4 Gene Therapy
        1.2.5 The Surgical Treatment
        1.2.6 Other
    1.3 Market by Application
        1.3.1 Global Retinitis Pigmentosa (Retinitis) Market Share by Application: 2017 VS 2021 VS 2028
        1.3.2 Hospitals
        1.3.3 Eye Clinics
        1.3.4 Other
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Retinitis Pigmentosa (Retinitis) Market Perspective (2017-2028)
    2.2 Retinitis Pigmentosa (Retinitis) Growth Trends by Region
        2.2.1 Retinitis Pigmentosa (Retinitis) Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Retinitis Pigmentosa (Retinitis) Historic Market Size by Region (2017-2022)
        2.2.3 Retinitis Pigmentosa (Retinitis) Forecasted Market Size by Region (2023-2028)
    2.3 Retinitis Pigmentosa (Retinitis) Market Dynamics
        2.3.1 Retinitis Pigmentosa (Retinitis) Industry Trends
        2.3.2 Retinitis Pigmentosa (Retinitis) Market Drivers
        2.3.3 Retinitis Pigmentosa (Retinitis) Market Challenges
        2.3.4 Retinitis Pigmentosa (Retinitis) Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Retinitis Pigmentosa (Retinitis) Players by Revenue
        3.1.1 Global Top Retinitis Pigmentosa (Retinitis) Players by Revenue (2017-2022)
        3.1.2 Global Retinitis Pigmentosa (Retinitis) Revenue Market Share by Players (2017-2022)
    3.2 Global Retinitis Pigmentosa (Retinitis) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Retinitis Pigmentosa (Retinitis) Revenue
    3.4 Global Retinitis Pigmentosa (Retinitis) Market Concentration Ratio
        3.4.1 Global Retinitis Pigmentosa (Retinitis) Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Retinitis Pigmentosa (Retinitis) Revenue in 2021
    3.5 Retinitis Pigmentosa (Retinitis) Key Players Head office and Area Served
    3.6 Key Players Retinitis Pigmentosa (Retinitis) Product Solution and Service
    3.7 Date of Enter into Retinitis Pigmentosa (Retinitis) Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Retinitis Pigmentosa (Retinitis) Breakdown Data by Type
    4.1 Global Retinitis Pigmentosa (Retinitis) Historic Market Size by Type (2017-2022)
    4.2 Global Retinitis Pigmentosa (Retinitis) Forecasted Market Size by Type (2023-2028)
5 Retinitis Pigmentosa (Retinitis) Breakdown Data by Application
    5.1 Global Retinitis Pigmentosa (Retinitis) Historic Market Size by Application (2017-2022)
    5.2 Global Retinitis Pigmentosa (Retinitis) Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Retinitis Pigmentosa (Retinitis) Market Size (2017-2028)
    6.2 North America Retinitis Pigmentosa (Retinitis) Market Size by Country (2017-2022)
    6.3 North America Retinitis Pigmentosa (Retinitis) Market Size by Country (2023-2028)
    6.4 United States
    6.5 Canada
7 Europe
    7.1 Europe Retinitis Pigmentosa (Retinitis) Market Size (2017-2028)
    7.2 Europe Retinitis Pigmentosa (Retinitis) Market Size by Country (2017-2022)
    7.3 Europe Retinitis Pigmentosa (Retinitis) Market Size by Country (2023-2028)
    7.4 Germany
    7.5 France
    7.6 U.K.
    7.7 Italy
    7.8 Russia
    7.9 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Retinitis Pigmentosa (Retinitis) Market Size (2017-2028)
    8.2 Asia-Pacific Retinitis Pigmentosa (Retinitis) Market Size by Country (2017-2022)
    8.3 Asia-Pacific Retinitis Pigmentosa (Retinitis) Market Size by Country (2023-2028)
    8.4 China
    8.5 Japan
    8.6 South Korea
    8.7 Southeast Asia
    8.8 India
    8.9 Australia
9 Latin America
    9.1 Latin America Retinitis Pigmentosa (Retinitis) Market Size (2017-2028)
    9.2 Latin America Retinitis Pigmentosa (Retinitis) Market Size by Country (2017-2022)
    9.3 Latin America Retinitis Pigmentosa (Retinitis) Market Size by Country (2023-2028)
    9.4 Mexico
    9.5 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Retinitis Pigmentosa (Retinitis) Market Size (2017-2028)
    10.2 Middle East & Africa Retinitis Pigmentosa (Retinitis) Market Size by Country (2017-2022)
    10.3 Middle East & Africa Retinitis Pigmentosa (Retinitis) Market Size by Country (2023-2028)
    10.4 Turkey
    10.5 Saudi Arabia
    10.6 UAE
11 Key Players Profiles
    11.1 Sanofi
        11.1.1 Sanofi Company Detail
        11.1.2 Sanofi Business Overview
        11.1.3 Sanofi Retinitis Pigmentosa (Retinitis) Introduction
        11.1.4 Sanofi Revenue in Retinitis Pigmentosa (Retinitis) Business (2017-2022)
        11.1.5 Sanofi Recent Development
    11.2 Amgen
        11.2.1 Amgen Company Detail
        11.2.2 Amgen Business Overview
        11.2.3 Amgen Retinitis Pigmentosa (Retinitis) Introduction
        11.2.4 Amgen Revenue in Retinitis Pigmentosa (Retinitis) Business (2017-2022)
        11.2.5 Amgen Recent Development
    11.3 Amarantus Bioscience Holdings
        11.3.1 Amarantus Bioscience Holdings Company Detail
        11.3.2 Amarantus Bioscience Holdings Business Overview
        11.3.3 Amarantus Bioscience Holdings Retinitis Pigmentosa (Retinitis) Introduction
        11.3.4 Amarantus Bioscience Holdings Revenue in Retinitis Pigmentosa (Retinitis) Business (2017-2022)
        11.3.5 Amarantus Bioscience Holdings Recent Development
    11.4 Acucela
        11.4.1 Acucela Company Detail
        11.4.2 Acucela Business Overview
        11.4.3 Acucela Retinitis Pigmentosa (Retinitis) Introduction
        11.4.4 Acucela Revenue in Retinitis Pigmentosa (Retinitis) Business (2017-2022)
        11.4.5 Acucela Recent Development
    11.5 Applied Genetic Technologies Corp
        11.5.1 Applied Genetic Technologies Corp Company Detail
        11.5.2 Applied Genetic Technologies Corp Business Overview
        11.5.3 Applied Genetic Technologies Corp Retinitis Pigmentosa (Retinitis) Introduction
        11.5.4 Applied Genetic Technologies Corp Revenue in Retinitis Pigmentosa (Retinitis) Business (2017-2022)
        11.5.5 Applied Genetic Technologies Corp Recent Development
    11.6 Asklepios BioPharmaceutical
        11.6.1 Asklepios BioPharmaceutical Company Detail
        11.6.2 Asklepios BioPharmaceutical Business Overview
        11.6.3 Asklepios BioPharmaceutical Retinitis Pigmentosa (Retinitis) Introduction
        11.6.4 Asklepios BioPharmaceutical Revenue in Retinitis Pigmentosa (Retinitis) Business (2017-2022)
        11.6.5 Asklepios BioPharmaceutical Recent Development
    11.7 Astellas Pharma
        11.7.1 Astellas Pharma Company Detail
        11.7.2 Astellas Pharma Business Overview
        11.7.3 Astellas Pharma Retinitis Pigmentosa (Retinitis) Introduction
        11.7.4 Astellas Pharma Revenue in Retinitis Pigmentosa (Retinitis) Business (2017-2022)
        11.7.5 Astellas Pharma Recent Development
    11.8 Caladrius Biosciences
        11.8.1 Caladrius Biosciences Company Detail
        11.8.2 Caladrius Biosciences Business Overview
        11.8.3 Caladrius Biosciences Retinitis Pigmentosa (Retinitis) Introduction
        11.8.4 Caladrius Biosciences Revenue in Retinitis Pigmentosa (Retinitis) Business (2017-2022)
        11.8.5 Caladrius Biosciences Recent Development
    11.9 Dompe Farmaceutici SpA
        11.9.1 Dompe Farmaceutici SpA Company Detail
        11.9.2 Dompe Farmaceutici SpA Business Overview
        11.9.3 Dompe Farmaceutici SpA Retinitis Pigmentosa (Retinitis) Introduction
        11.9.4 Dompe Farmaceutici SpA Revenue in Retinitis Pigmentosa (Retinitis) Business (2017-2022)
        11.9.5 Dompe Farmaceutici SpA Recent Development
    11.10 Dormant Projects
        11.10.1 Dormant Projects Company Detail
        11.10.2 Dormant Projects Business Overview
        11.10.3 Dormant Projects Retinitis Pigmentosa (Retinitis) Introduction
        11.10.4 Dormant Projects Revenue in Retinitis Pigmentosa (Retinitis) Business (2017-2022)
        11.10.5 Dormant Projects Recent Development
    11.11 GenSight Biologics SA
        11.11.1 GenSight Biologics SA Company Detail
        11.11.2 GenSight Biologics SA Business Overview
        11.11.3 GenSight Biologics SA Retinitis Pigmentosa (Retinitis) Introduction
        11.11.4 GenSight Biologics SA Revenue in Retinitis Pigmentosa (Retinitis) Business (2017-2022)
        11.11.5 GenSight Biologics SA Recent Development
    11.12 Grupo Ferrer Internacional SA
        11.12.1 Grupo Ferrer Internacional SA Company Detail
        11.12.2 Grupo Ferrer Internacional SA Business Overview
        11.12.3 Grupo Ferrer Internacional SA Retinitis Pigmentosa (Retinitis) Introduction
        11.12.4 Grupo Ferrer Internacional SA Revenue in Retinitis Pigmentosa (Retinitis) Business (2017-2022)
        11.12.5 Grupo Ferrer Internacional SA Recent Development
    11.13 ID Pharma
        11.13.1 ID Pharma Company Detail
        11.13.2 ID Pharma Business Overview
        11.13.3 ID Pharma Retinitis Pigmentosa (Retinitis) Introduction
        11.13.4 ID Pharma Revenue in Retinitis Pigmentosa (Retinitis) Business (2017-2022)
        11.13.5 ID Pharma Recent Development
    11.14 InFlectis BioScience
        11.14.1 InFlectis BioScience Company Detail
        11.14.2 InFlectis BioScience Business Overview
        11.14.3 InFlectis BioScience Retinitis Pigmentosa (Retinitis) Introduction
        11.14.4 InFlectis BioScience Revenue in Retinitis Pigmentosa (Retinitis) Business (2017-2022)
        11.14.5 InFlectis BioScience Recent Development
    11.15 Ionis Pharmaceuticals
        11.15.1 Ionis Pharmaceuticals Company Detail
        11.15.2 Ionis Pharmaceuticals Business Overview
        11.15.3 Ionis Pharmaceuticals Retinitis Pigmentosa (Retinitis) Introduction
        11.15.4 Ionis Pharmaceuticals Revenue in Retinitis Pigmentosa (Retinitis) Business (2017-2022)
        11.15.5 Ionis Pharmaceuticals Recent Development
    11.16 Mimetogen Pharmaceuticals
        11.16.1 Mimetogen Pharmaceuticals Company Detail
        11.16.2 Mimetogen Pharmaceuticals Business Overview
        11.16.3 Mimetogen Pharmaceuticals Retinitis Pigmentosa (Retinitis) Introduction
        11.16.4 Mimetogen Pharmaceuticals Revenue in Retinitis Pigmentosa (Retinitis) Business (2017-2022)
        11.16.5 Mimetogen Pharmaceuticals Recent Development
    11.17 M's Science Corp
        11.17.1 M's Science Corp Company Detail
        11.17.2 M's Science Corp Business Overview
        11.17.3 M's Science Corp Retinitis Pigmentosa (Retinitis) Introduction
        11.17.4 M's Science Corp Revenue in Retinitis Pigmentosa (Retinitis) Business (2017-2022)
        11.17.5 M's Science Corp Recent Development
    11.18 Nanovector srl
        11.18.1 Nanovector srl Company Detail
        11.18.2 Nanovector srl Business Overview
        11.18.3 Nanovector srl Retinitis Pigmentosa (Retinitis) Introduction
        11.18.4 Nanovector srl Revenue in Retinitis Pigmentosa (Retinitis) Business (2017-2022)
        11.18.5 Nanovector srl Recent Development
    11.19 Novartis AG
        11.19.1 Novartis AG Company Detail
        11.19.2 Novartis AG Business Overview
        11.19.3 Novartis AG Retinitis Pigmentosa (Retinitis) Introduction
        11.19.4 Novartis AG Revenue in Retinitis Pigmentosa (Retinitis) Business (2017-2022)
        11.19.5 Novartis AG Recent Development
    11.20 Novelion Therapeutics
        11.20.1 Novelion Therapeutics Company Detail
        11.20.2 Novelion Therapeutics Business Overview
        11.20.3 Novelion Therapeutics Retinitis Pigmentosa (Retinitis) Introduction
        11.20.4 Novelion Therapeutics Revenue in Retinitis Pigmentosa (Retinitis) Business (2017-2022)
        11.20.5 Novelion Therapeutics Recent Development
    11.21 ProQR Therapeutics
        11.21.1 ProQR Therapeutics Company Detail
        11.21.2 ProQR Therapeutics Business Overview
        11.21.3 ProQR Therapeutics Retinitis Pigmentosa (Retinitis) Introduction
        11.21.4 ProQR Therapeutics Revenue in Retinitis Pigmentosa (Retinitis) Business (2017-2022)
        11.21.5 ProQR Therapeutics Recent Development
    11.22 ReNeuron Group Plc
        11.22.1 ReNeuron Group Plc Company Detail
        11.22.2 ReNeuron Group Plc Business Overview
        11.22.3 ReNeuron Group Plc Retinitis Pigmentosa (Retinitis) Introduction
        11.22.4 ReNeuron Group Plc Revenue in Retinitis Pigmentosa (Retinitis) Business (2017-2022)
        11.22.5 ReNeuron Group Plc Recent Development
    11.23 SanBio
        11.23.1 SanBio Company Detail
        11.23.2 SanBio Business Overview
        11.23.3 SanBio Retinitis Pigmentosa (Retinitis) Introduction
        11.23.4 SanBio Revenue in Retinitis Pigmentosa (Retinitis) Business (2017-2022)
        11.23.5 SanBio Recent Development
    11.24 Shire (Takeda Pharmaceutical)
        11.24.1 Shire (Takeda Pharmaceutical) Company Detail
        11.24.2 Shire (Takeda Pharmaceutical) Business Overview
        11.24.3 Shire (Takeda Pharmaceutical) Retinitis Pigmentosa (Retinitis) Introduction
        11.24.4 Shire (Takeda Pharmaceutical) Revenue in Retinitis Pigmentosa (Retinitis) Business (2017-2022)
        11.24.5 Shire (Takeda Pharmaceutical) Recent Development
    11.25 Spark Therapeutics
        11.25.1 Spark Therapeutics Company Detail
        11.25.2 Spark Therapeutics Business Overview
        11.25.3 Spark Therapeutics Retinitis Pigmentosa (Retinitis) Introduction
        11.25.4 Spark Therapeutics Revenue in Retinitis Pigmentosa (Retinitis) Business (2017-2022)
        11.25.5 Spark Therapeutics Recent Development
    11.26 Sun Pharma Advanced Research Company
        11.26.1 Sun Pharma Advanced Research Company Company Detail
        11.26.2 Sun Pharma Advanced Research Company Business Overview
        11.26.3 Sun Pharma Advanced Research Company Retinitis Pigmentosa (Retinitis) Introduction
        11.26.4 Sun Pharma Advanced Research Company Revenue in Retinitis Pigmentosa (Retinitis) Business (2017-2022)
        11.26.5 Sun Pharma Advanced Research Company Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details

List of Tables
    Table 1. Global Retinitis Pigmentosa (Retinitis) Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
    Table 2. Key Players of General Treatment
    Table 3. Key Players of Traditional Chinese Medicine
    Table 4. Key Players of Gene Therapy
    Table 5. Key Players of The Surgical Treatment
    Table 6. Key Players of Other
    Table 7. Global Retinitis Pigmentosa (Retinitis) Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
    Table 8. Global Retinitis Pigmentosa (Retinitis) Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 9. Global Retinitis Pigmentosa (Retinitis) Market Size by Region (2017-2022) & (US$ Million)
    Table 10. Global Retinitis Pigmentosa (Retinitis) Market Share by Region (2017-2022)
    Table 11. Global Retinitis Pigmentosa (Retinitis) Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 12. Global Retinitis Pigmentosa (Retinitis) Market Share by Region (2023-2028)
    Table 13. Retinitis Pigmentosa (Retinitis) Market Trends
    Table 14. Retinitis Pigmentosa (Retinitis) Market Drivers
    Table 15. Retinitis Pigmentosa (Retinitis) Market Challenges
    Table 16. Retinitis Pigmentosa (Retinitis) Market Restraints
    Table 17. Global Retinitis Pigmentosa (Retinitis) Revenue by Players (2017-2022) & (US$ Million)
    Table 18. Global Retinitis Pigmentosa (Retinitis) Market Share by Players (2017-2022)
    Table 19. Global Top Retinitis Pigmentosa (Retinitis) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Retinitis Pigmentosa (Retinitis) as of 2021)
    Table 20. Ranking of Global Top Retinitis Pigmentosa (Retinitis) Companies by Revenue (US$ Million) in 2021
    Table 21. Global 5 Largest Players Market Share by Retinitis Pigmentosa (Retinitis) Revenue (CR5 and HHI) & (2017-2022)
    Table 22. Key Players Headquarters and Area Served
    Table 23. Key Players Retinitis Pigmentosa (Retinitis) Product Solution and Service
    Table 24. Date of Enter into Retinitis Pigmentosa (Retinitis) Market
    Table 25. Mergers & Acquisitions, Expansion Plans
    Table 26. Global Retinitis Pigmentosa (Retinitis) Market Size by Type (2017-2022) & (US$ Million)
    Table 27. Global Retinitis Pigmentosa (Retinitis) Revenue Market Share by Type (2017-2022)
    Table 28. Global Retinitis Pigmentosa (Retinitis) Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 29. Global Retinitis Pigmentosa (Retinitis) Revenue Market Share by Type (2023-2028)
    Table 30. Global Retinitis Pigmentosa (Retinitis) Market Size by Application (2017-2022) & (US$ Million)
    Table 31. Global Retinitis Pigmentosa (Retinitis) Revenue Market Share by Application (2017-2022)
    Table 32. Global Retinitis Pigmentosa (Retinitis) Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 33. Global Retinitis Pigmentosa (Retinitis) Revenue Market Share by Application (2023-2028)
    Table 34. North America Retinitis Pigmentosa (Retinitis) Market Size by Country (2017-2022) & (US$ Million)
    Table 35. North America Retinitis Pigmentosa (Retinitis) Market Size by Country (2023-2028) & (US$ Million)
    Table 36. Europe Retinitis Pigmentosa (Retinitis) Market Size by Country (2017-2022) & (US$ Million)
    Table 37. Europe Retinitis Pigmentosa (Retinitis) Market Size by Country (2023-2028) & (US$ Million)
    Table 38. Asia-Pacific Retinitis Pigmentosa (Retinitis) Market Size by Region (2017-2022) & (US$ Million)
    Table 39. Asia-Pacific Retinitis Pigmentosa (Retinitis) Market Size by Region (2023-2028) & (US$ Million)
    Table 40. Latin America Retinitis Pigmentosa (Retinitis) Market Size by Country (2017-2022) & (US$ Million)
    Table 41. Latin America Retinitis Pigmentosa (Retinitis) Market Size by Country (2023-2028) & (US$ Million)
    Table 42. Middle East & Africa Retinitis Pigmentosa (Retinitis) Market Size by Country (2017-2022) & (US$ Million)
    Table 43. Middle East & Africa Retinitis Pigmentosa (Retinitis) Market Size by Country (2023-2028) & (US$ Million)
    Table 44. Sanofi Company Detail
    Table 45. Sanofi Business Overview
    Table 46. Sanofi Retinitis Pigmentosa (Retinitis) Product
    Table 47. Sanofi Revenue in Retinitis Pigmentosa (Retinitis) Business (2017-2022) & (US$ Million)
    Table 48. Sanofi Recent Development
    Table 49. Amgen Company Detail
    Table 50. Amgen Business Overview
    Table 51. Amgen Retinitis Pigmentosa (Retinitis) Product
    Table 52. Amgen Revenue in Retinitis Pigmentosa (Retinitis) Business (2017-2022) & (US$ Million)
    Table 53. Amgen Recent Development
    Table 54. Amarantus Bioscience Holdings Company Detail
    Table 55. Amarantus Bioscience Holdings Business Overview
    Table 56. Amarantus Bioscience Holdings Retinitis Pigmentosa (Retinitis) Product
    Table 57. Amarantus Bioscience Holdings Revenue in Retinitis Pigmentosa (Retinitis) Business (2017-2022) & (US$ Million)
    Table 58. Amarantus Bioscience Holdings Recent Development
    Table 59. Acucela Company Detail
    Table 60. Acucela Business Overview
    Table 61. Acucela Retinitis Pigmentosa (Retinitis) Product
    Table 62. Acucela Revenue in Retinitis Pigmentosa (Retinitis) Business (2017-2022) & (US$ Million)
    Table 63. Acucela Recent Development
    Table 64. Applied Genetic Technologies Corp Company Detail
    Table 65. Applied Genetic Technologies Corp Business Overview
    Table 66. Applied Genetic Technologies Corp Retinitis Pigmentosa (Retinitis) Product
    Table 67. Applied Genetic Technologies Corp Revenue in Retinitis Pigmentosa (Retinitis) Business (2017-2022) & (US$ Million)
    Table 68. Applied Genetic Technologies Corp Recent Development
    Table 69. Asklepios BioPharmaceutical Company Detail
    Table 70. Asklepios BioPharmaceutical Business Overview
    Table 71. Asklepios BioPharmaceutical Retinitis Pigmentosa (Retinitis) Product
    Table 72. Asklepios BioPharmaceutical Revenue in Retinitis Pigmentosa (Retinitis) Business (2017-2022) & (US$ Million)
    Table 73. Asklepios BioPharmaceutical Recent Development
    Table 74. Astellas Pharma Company Detail
    Table 75. Astellas Pharma Business Overview
    Table 76. Astellas Pharma Retinitis Pigmentosa (Retinitis) Product
    Table 77. Astellas Pharma Revenue in Retinitis Pigmentosa (Retinitis) Business (2017-2022) & (US$ Million)
    Table 78. Astellas Pharma Recent Development
    Table 79. Caladrius Biosciences Company Detail
    Table 80. Caladrius Biosciences Business Overview
    Table 81. Caladrius Biosciences Retinitis Pigmentosa (Retinitis) Product
    Table 82. Caladrius Biosciences Revenue in Retinitis Pigmentosa (Retinitis) Business (2017-2022) & (US$ Million)
    Table 83. Caladrius Biosciences Recent Development
    Table 84. Dompe Farmaceutici SpA Company Detail
    Table 85. Dompe Farmaceutici SpA Business Overview
    Table 86. Dompe Farmaceutici SpA Retinitis Pigmentosa (Retinitis) Product
    Table 87. Dompe Farmaceutici SpA Revenue in Retinitis Pigmentosa (Retinitis) Business (2017-2022) & (US$ Million)
    Table 88. Dompe Farmaceutici SpA Recent Development
    Table 89. Dormant Projects Company Detail
    Table 90. Dormant Projects Business Overview
    Table 91. Dormant Projects Retinitis Pigmentosa (Retinitis) Product
    Table 92. Dormant Projects Revenue in Retinitis Pigmentosa (Retinitis) Business (2017-2022) & (US$ Million)
    Table 93. Dormant Projects Recent Development
    Table 94. GenSight Biologics SA Company Detail
    Table 95. GenSight Biologics SA Business Overview
    Table 96. GenSight Biologics SA Retinitis Pigmentosa (Retinitis)Product
    Table 97. GenSight Biologics SA Revenue in Retinitis Pigmentosa (Retinitis) Business (2017-2022) & (US$ Million)
    Table 98. GenSight Biologics SA Recent Development
    Table 99. Grupo Ferrer Internacional SA Company Detail
    Table 100. Grupo Ferrer Internacional SA Business Overview
    Table 101. Grupo Ferrer Internacional SA Retinitis Pigmentosa (Retinitis)Product
    Table 102. Grupo Ferrer Internacional SA Revenue in Retinitis Pigmentosa (Retinitis) Business (2017-2022) & (US$ Million)
    Table 103. Grupo Ferrer Internacional SA Recent Development
    Table 104. ID Pharma Company Detail
    Table 105. ID Pharma Business Overview
    Table 106. ID Pharma Retinitis Pigmentosa (Retinitis)Product
    Table 107. ID Pharma Revenue in Retinitis Pigmentosa (Retinitis) Business (2017-2022) & (US$ Million)
    Table 108. ID Pharma Recent Development
    Table 109. InFlectis BioScience Company Detail
    Table 110. InFlectis BioScience Business Overview
    Table 111. InFlectis BioScience Retinitis Pigmentosa (Retinitis)Product
    Table 112. InFlectis BioScience Revenue in Retinitis Pigmentosa (Retinitis) Business (2017-2022) & (US$ Million)
    Table 113. InFlectis BioScience Recent Development
    Table 114. Ionis Pharmaceuticals Company Detail
    Table 115. Ionis Pharmaceuticals Business Overview
    Table 116. Ionis Pharmaceuticals Retinitis Pigmentosa (Retinitis)Product
    Table 117. Ionis Pharmaceuticals Revenue in Retinitis Pigmentosa (Retinitis) Business (2017-2022) & (US$ Million)
    Table 118. Ionis Pharmaceuticals Recent Development
    Table 119. Mimetogen Pharmaceuticals Company Detail
    Table 120. Mimetogen Pharmaceuticals Business Overview
    Table 121. Mimetogen Pharmaceuticals Retinitis Pigmentosa (Retinitis)Product
    Table 122. Mimetogen Pharmaceuticals Revenue in Retinitis Pigmentosa (Retinitis) Business (2017-2022) & (US$ Million)
    Table 123. Mimetogen Pharmaceuticals Recent Development
    Table 124. M's Science Corp Company Detail
    Table 125. M's Science Corp Business Overview
    Table 126. M's Science Corp Retinitis Pigmentosa (Retinitis)Product
    Table 127. M's Science Corp Revenue in Retinitis Pigmentosa (Retinitis) Business (2017-2022) & (US$ Million)
    Table 128. M's Science Corp Recent Development
    Table 129. Nanovector srl Company Detail
    Table 130. Nanovector srl Business Overview
    Table 131. Nanovector srl Retinitis Pigmentosa (Retinitis)Product
    Table 132. Nanovector srl Revenue in Retinitis Pigmentosa (Retinitis) Business (2017-2022) & (US$ Million)
    Table 133. Nanovector srl Recent Development
    Table 134. Novartis AG Company Detail
    Table 135. Novartis AG Business Overview
    Table 136. Novartis AG Retinitis Pigmentosa (Retinitis)Product
    Table 137. Novartis AG Revenue in Retinitis Pigmentosa (Retinitis) Business (2017-2022) & (US$ Million)
    Table 138. Novartis AG Recent Development
    Table 139. Novelion Therapeutics Company Detail
    Table 140. Novelion Therapeutics Business Overview
    Table 141. Novelion Therapeutics Retinitis Pigmentosa (Retinitis)Product
    Table 142. Novelion Therapeutics Revenue in Retinitis Pigmentosa (Retinitis) Business (2017-2022) & (US$ Million)
    Table 143. Novelion Therapeutics Recent Development
    Table 144. ProQR Therapeutics Company Detail
    Table 145. ProQR Therapeutics Business Overview
    Table 146. ProQR Therapeutics Retinitis Pigmentosa (Retinitis)Product
    Table 147. ProQR Therapeutics Revenue in Retinitis Pigmentosa (Retinitis) Business (2017-2022) & (US$ Million)
    Table 148. ProQR Therapeutics Recent Development
    Table 149. ReNeuron Group Plc Company Detail
    Table 150. ReNeuron Group Plc Business Overview
    Table 151. ReNeuron Group Plc Retinitis Pigmentosa (Retinitis)Product
    Table 152. ReNeuron Group Plc Revenue in Retinitis Pigmentosa (Retinitis) Business (2017-2022) & (US$ Million)
    Table 153. ReNeuron Group Plc Recent Development
    Table 154. SanBio Company Detail
    Table 155. SanBio Business Overview
    Table 156. SanBio Retinitis Pigmentosa (Retinitis)Product
    Table 157. SanBio Revenue in Retinitis Pigmentosa (Retinitis) Business (2017-2022) & (US$ Million)
    Table 158. SanBio Recent Development
    Table 159. Shire (Takeda Pharmaceutical) Company Detail
    Table 160. Shire (Takeda Pharmaceutical) Business Overview
    Table 161. Shire (Takeda Pharmaceutical) Retinitis Pigmentosa (Retinitis)Product
    Table 162. Shire (Takeda Pharmaceutical) Revenue in Retinitis Pigmentosa (Retinitis) Business (2017-2022) & (US$ Million)
    Table 163. Shire (Takeda Pharmaceutical) Recent Development
    Table 164. Spark Therapeutics Company Detail
    Table 165. Spark Therapeutics Business Overview
    Table 166. Spark Therapeutics Retinitis Pigmentosa (Retinitis)Product
    Table 167. Spark Therapeutics Revenue in Retinitis Pigmentosa (Retinitis) Business (2017-2022) & (US$ Million)
    Table 168. Spark Therapeutics Recent Development
    Table 169. Sun Pharma Advanced Research Company Company Detail
    Table 170. Sun Pharma Advanced Research Company Business Overview
    Table 171. Sun Pharma Advanced Research Company Retinitis Pigmentosa (Retinitis)Product
    Table 172. Sun Pharma Advanced Research Company Revenue in Retinitis Pigmentosa (Retinitis) Business (2017-2022) & (US$ Million)
    Table 173. Sun Pharma Advanced Research Company Recent Development
    Table 174. Research Programs/Design for This Report
    Table 175. Key Data Information from Secondary Sources
    Table 176. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Retinitis Pigmentosa (Retinitis) Market Share by Type: 2021 VS 2028
    Figure 2. General Treatment Features
    Figure 3. Traditional Chinese Medicine Features
    Figure 4. Gene Therapy Features
    Figure 5. The Surgical Treatment Features
    Figure 6. Other Features
    Figure 7. Global Retinitis Pigmentosa (Retinitis) Market Share by Application in 2021 & 2028
    Figure 8. Hospitals Case Studies
    Figure 9. Eye Clinics Case Studies
    Figure 10. Other Case Studies
    Figure 11. Retinitis Pigmentosa (Retinitis) Report Years Considered
    Figure 12. Global Retinitis Pigmentosa (Retinitis) Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 13. Global Retinitis Pigmentosa (Retinitis) Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 14. Global Retinitis Pigmentosa (Retinitis) Market Share by Region: 2021 VS 2028
    Figure 15. Global Retinitis Pigmentosa (Retinitis) Market Share by Players in 2021
    Figure 16. Global Top Retinitis Pigmentosa (Retinitis) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Retinitis Pigmentosa (Retinitis) as of 2021)
    Figure 17. The Top 10 and 5 Players Market Share by Retinitis Pigmentosa (Retinitis) Revenue in 2021
    Figure 18. North America Retinitis Pigmentosa (Retinitis) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 19. North America Retinitis Pigmentosa (Retinitis) Market Share by Country (2017-2028)
    Figure 20. United States Retinitis Pigmentosa (Retinitis) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 21. Canada Retinitis Pigmentosa (Retinitis) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 22. Europe Retinitis Pigmentosa (Retinitis) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 23. Europe Retinitis Pigmentosa (Retinitis) Market Share by Country (2017-2028)
    Figure 24. Germany Retinitis Pigmentosa (Retinitis) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 25. France Retinitis Pigmentosa (Retinitis) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. U.K. Retinitis Pigmentosa (Retinitis) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. Italy Retinitis Pigmentosa (Retinitis) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. Russia Retinitis Pigmentosa (Retinitis) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. Nordic Countries Retinitis Pigmentosa (Retinitis) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Asia-Pacific Retinitis Pigmentosa (Retinitis) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. Asia-Pacific Retinitis Pigmentosa (Retinitis) Market Share by Region (2017-2028)
    Figure 32. China Retinitis Pigmentosa (Retinitis) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. Japan Retinitis Pigmentosa (Retinitis) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. South Korea Retinitis Pigmentosa (Retinitis) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. Southeast Asia Retinitis Pigmentosa (Retinitis) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. India Retinitis Pigmentosa (Retinitis) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. Australia Retinitis Pigmentosa (Retinitis) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. Latin America Retinitis Pigmentosa (Retinitis) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. Latin America Retinitis Pigmentosa (Retinitis) Market Share by Country (2017-2028)
    Figure 40. Mexico Retinitis Pigmentosa (Retinitis) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. Brazil Retinitis Pigmentosa (Retinitis) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. Middle East & Africa Retinitis Pigmentosa (Retinitis) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 43. Middle East & Africa Retinitis Pigmentosa (Retinitis) Market Share by Country (2017-2028)
    Figure 44. Turkey Retinitis Pigmentosa (Retinitis) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 45. Saudi Arabia Retinitis Pigmentosa (Retinitis) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 46. Sanofi Revenue Growth Rate in Retinitis Pigmentosa (Retinitis) Business (2017-2022)
    Figure 47. Amgen Revenue Growth Rate in Retinitis Pigmentosa (Retinitis) Business (2017-2022)
    Figure 48. Amarantus Bioscience Holdings Revenue Growth Rate in Retinitis Pigmentosa (Retinitis) Business (2017-2022)
    Figure 49. Acucela Revenue Growth Rate in Retinitis Pigmentosa (Retinitis) Business (2017-2022)
    Figure 50. Applied Genetic Technologies Corp Revenue Growth Rate in Retinitis Pigmentosa (Retinitis) Business (2017-2022)
    Figure 51. Asklepios BioPharmaceutical Revenue Growth Rate in Retinitis Pigmentosa (Retinitis) Business (2017-2022)
    Figure 52. Astellas Pharma Revenue Growth Rate in Retinitis Pigmentosa (Retinitis) Business (2017-2022)
    Figure 53. Caladrius Biosciences Revenue Growth Rate in Retinitis Pigmentosa (Retinitis) Business (2017-2022)
    Figure 54. Dompe Farmaceutici SpA Revenue Growth Rate in Retinitis Pigmentosa (Retinitis) Business (2017-2022)
    Figure 55. Dormant Projects Revenue Growth Rate in Retinitis Pigmentosa (Retinitis) Business (2017-2022)
    Figure 56. GenSight Biologics SA Revenue Growth Rate in Retinitis Pigmentosa (Retinitis) Business (2017-2022)
    Figure 57. Grupo Ferrer Internacional SA Revenue Growth Rate in Retinitis Pigmentosa (Retinitis) Business (2017-2022)
    Figure 58. ID Pharma Revenue Growth Rate in Retinitis Pigmentosa (Retinitis) Business (2017-2022)
    Figure 59. InFlectis BioScience Revenue Growth Rate in Retinitis Pigmentosa (Retinitis) Business (2017-2022)
    Figure 60. Ionis Pharmaceuticals Revenue Growth Rate in Retinitis Pigmentosa (Retinitis) Business (2017-2022)
    Figure 61. Mimetogen Pharmaceuticals Revenue Growth Rate in Retinitis Pigmentosa (Retinitis) Business (2017-2022)
    Figure 62. M's Science Corp Revenue Growth Rate in Retinitis Pigmentosa (Retinitis) Business (2017-2022)
    Figure 63. Nanovector srl Revenue Growth Rate in Retinitis Pigmentosa (Retinitis) Business (2017-2022)
    Figure 64. Novartis AG Revenue Growth Rate in Retinitis Pigmentosa (Retinitis) Business (2017-2022)
    Figure 65. Novelion Therapeutics Revenue Growth Rate in Retinitis Pigmentosa (Retinitis) Business (2017-2022)
    Figure 66. ProQR Therapeutics Revenue Growth Rate in Retinitis Pigmentosa (Retinitis) Business (2017-2022)
    Figure 67. ReNeuron Group Plc Revenue Growth Rate in Retinitis Pigmentosa (Retinitis) Business (2017-2022)
    Figure 68. SanBio Revenue Growth Rate in Retinitis Pigmentosa (Retinitis) Business (2017-2022)
    Figure 69. Shire (Takeda Pharmaceutical) Revenue Growth Rate in Retinitis Pigmentosa (Retinitis) Business (2017-2022)
    Figure 70. Spark Therapeutics Revenue Growth Rate in Retinitis Pigmentosa (Retinitis) Business (2017-2022)
    Figure 71. Sun Pharma Advanced Research Company Revenue Growth Rate in Retinitis Pigmentosa (Retinitis) Business (2017-2022)
    Figure 72. Bottom-up and Top-down Approaches for This Report
    Figure 73. Data Triangulation
    Figure 74. Key Executives Interviewed

Please ask for List of Figures. Request Sample Report

Companies Included in Reports:

Sanofi
Amgen
Amarantus Bioscience Holdings
Acucela
Applied Genetic Technologies Corp
Asklepios BioPharmaceutical
Astellas Pharma
Caladrius Biosciences
Dompe Farmaceutici SpA
Dormant Projects
GenSight Biologics SA
Grupo Ferrer Internacional SA
ID Pharma
InFlectis BioScience
Ionis Pharmaceuticals
Mimetogen Pharmaceuticals
M's Science Corp
Nanovector srl
Novartis AG
Novelion Therapeutics
ProQR Therapeutics
ReNeuron Group Plc
SanBio
Shire (Takeda Pharmaceutical)
Spark Therapeutics
Sun Pharma Advanced Research Company

Choose License

Single User License
1-3 Users License
Multi User License
4-15 User License
Enterprise License
Unlimited User License

Price:
$2900
For Single License
BUY NOW
Request Discount

The research report includes specific segments by region (country), by manufacturers, by Type and by Application.
Get Sample Report

Our Clients

Testimonials

"Excellent customer service by aniket and their team. Was on very tight scheduled and the team delivered it in like 12 hours. Deal closed."

Sergio Rossi
Managing Director & Partner

Included In The Report

Sales & Revenue Forecast

Regional Market Size

Competitor Analysis

Industry Trends

SWOT Analysis

Free Sample Report

Global Retinitis Pigmentosa (Retinitis) Market Research Report 2023

Global Retinitis Pigmentosa (Retinitis) Market Research Report 2023

Global Retinitis Pigmentosa (Retinitis) Market Research Report 2023

Global Retinitis Pigmentosa (Retinitis) Market Research Report 2023

Global Retinitis Pigmentosa (Retinitis) Market Research Report 2023

Global Retinitis Pigmentosa (Retinitis) Market Research Report 2023

Global Retinitis Pigmentosa (Retinitis) Market Research Report 2023

Global Retinitis Pigmentosa (Retinitis) Market Research Report 2023

Global Retinitis Pigmentosa (Retinitis) Market Research Report 2023

Global Retinitis Pigmentosa (Retinitis) Market Research Report 2023

Global Retinitis Pigmentosa (Retinitis) Market Research Report 2023

Global Retinitis Pigmentosa (Retinitis) Market Research Report 2023

Global Retinitis Pigmentosa (Retinitis) Market Research Report 2023

Global Retinitis Pigmentosa (Retinitis) Market Research Report 2023

Global Retinitis Pigmentosa (Retinitis) Market Research Report 2023

Global Retinitis Pigmentosa (Retinitis) Market Research Report 2023

Global Retinitis Pigmentosa (Retinitis) Market Research Report 2023

Global Retinitis Pigmentosa (Retinitis) Market Research Report 2023

Global Retinitis Pigmentosa (Retinitis) Market Research Report 2023

Global Retinitis Pigmentosa (Retinitis) Market Research Report 2023

Global Retinitis Pigmentosa (Retinitis) Market Research Report 2023

Global Retinitis Pigmentosa (Retinitis) Market Research Report 2023

Global Retinitis Pigmentosa (Retinitis) Market Research Report 2023

Global Retinitis Pigmentosa (Retinitis) Market Research Report 2023

Global Retinitis Pigmentosa (Retinitis) Market Research Report 2023

Global Retinitis Pigmentosa (Retinitis) Market Research Report 2023

Global Retinitis Pigmentosa (Retinitis) Market Research Report 2023

Global Retinitis Pigmentosa (Retinitis) Market Research Report 2023

Global Retinitis Pigmentosa (Retinitis) Market Research Report 2023

Global Retinitis Pigmentosa (Retinitis) Market Research Report 2023

Global Retinitis Pigmentosa (Retinitis) Market Research Report 2023

Global Retinitis Pigmentosa (Retinitis) Market Research Report 2023

Global Retinitis Pigmentosa (Retinitis) Market Research Report 2023

Global Retinitis Pigmentosa (Retinitis) Market Research Report 2023

Global Retinitis Pigmentosa (Retinitis) Market Research Report 2023

Global Retinitis Pigmentosa (Retinitis) Market Research Report 2023

Global Retinitis Pigmentosa (Retinitis) Market Research Report 2023

Global Retinitis Pigmentosa (Retinitis) Market Research Report 2023

Global Retinitis Pigmentosa (Retinitis) Market Research Report 2023

Global Retinitis Pigmentosa (Retinitis) Market Research Report 2023

Global Retinitis Pigmentosa (Retinitis) Market Research Report 2023

Global Retinitis Pigmentosa (Retinitis) Market Research Report 2023

Global Retinitis Pigmentosa (Retinitis) Market Research Report 2023

Global Retinitis Pigmentosa (Retinitis) Market Research Report 2023

Global Retinitis Pigmentosa (Retinitis) Market Research Report 2023

Global Retinitis Pigmentosa (Retinitis) Market Research Report 2023

Global Retinitis Pigmentosa (Retinitis) Market Research Report 2023

Global Retinitis Pigmentosa (Retinitis) Market Research Report 2023

Global Retinitis Pigmentosa (Retinitis) Market Research Report 2023

Global Retinitis Pigmentosa (Retinitis) Market Research Report 2023

Global Retinitis Pigmentosa (Retinitis) Market Research Report 2023

Global Retinitis Pigmentosa (Retinitis) Market Research Report 2023

Global Retinitis Pigmentosa (Retinitis) Market Research Report 2023

Global Retinitis Pigmentosa (Retinitis) Market Research Report 2023

Global Retinitis Pigmentosa (Retinitis) Market Research Report 2023

Global Retinitis Pigmentosa (Retinitis) Market Research Report 2023

Global Retinitis Pigmentosa (Retinitis) Market Research Report 2023

Global Retinitis Pigmentosa (Retinitis) Market Research Report 2023

Global Retinitis Pigmentosa (Retinitis) Market Research Report 2023

Global Retinitis Pigmentosa (Retinitis) Market Research Report 2023

Global Retinitis Pigmentosa (Retinitis) Market Research Report 2023

Companies Included in Reports:

Frequently Asked Questions

Related Reports

Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy)

Gas Detector and Personal Protective Equipment

Gas Analyzer Calibrators

Fourier Transform Infrared (FTIR) Spectrom